ABL1 and leukemia: For BCR-ABL-positive leukemia patients, RT-PCR targeting BCR-ABL is used, whereas multiparametric flow cytometry (mpFC) and allele-specific oligonucleotide real-time quantitative PCR are employed for patients with B and T cell malignancies [99].